Once-daily Rhinocort® offers unsurpassed efficacy, proven long-term safety, essentially no taste or added fragrance, and does not contain benzalkonium chloride or alcohol. Rhinocort® is the first-line treatment of choice for all patients with seasonal (intermittent) and perennial (persistent) allergic rhinitis, aged 6 years and over, suffering more than very mild or intermittent nasal symptoms. Rhinocort® also provides highly effective once-daily relief of the symptoms of nasal polyposis.Rhinocort® is approved for use in the treatment of allergic rhinitis and nasal polyps. Three different formulations of Rhinocort® are currently available – although not all formulations and strengths are available in all countries
- Rhinocort® Aqua™ aqueous nasal spray 32, 50, 64 and 100 µg strengths (alternative trademarks include: Budecort Nasal®, Pulmicort Nasal®, Rhinocortol® and Pulmicort Topinasal®)
- Rhinocort® Turbuhaler® nasal dry powder inhaler 100 µg strength (alternative trademarks include: Spirocort® Nasal Turbuhaler®)
- Rhinocort® pMDI pressurised metered-dose inhaler 50 µg strength (alternative trademarks include: Rhinocort® Nasal Inhaler)
